Gerard Saranza
Gerard Saranza publishes mostly in Neurology, Cellular and Molecular Neuroscience and Molecular Biology, on topics such as Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments and Genetic Neurodegenerative Diseases.
- World rank
- #3,004,513 of 7,710,434 ranked researchers
- Rank in Taiwan
- #20,446 of 57,035
- Works
- 62
- Citations
- 595
- Citations per work
- 9.6
What does Gerard Saranza research?
Gerard Saranza's work is mostly in Medicine (52%), Neuroscience (14%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3252.4%
- Medicine3252.4%
- Everything else1625.4%
- Life Sciences1422.2%
- 1Neurology44% of their works
- 2Cellular and Molecular Neuroscience14% of their works
- 3Molecular Biology5% of their works
- 4Rheumatology5% of their works
- 5Psychiatry and Mental health4% of their works
- 6Genetics4% of their works
Research topics
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Genetic Neurodegenerative Diseases
- Glycogen Storage Diseases and Myoclonus
- Botulinum Toxin and Related Neurological Disorders
- Genetics and Neurodevelopmental Disorders
- Hereditary Neurological Disorders
- Autoimmune Neurological Disorders and Treatments
Which keywords describe Gerard Saranza's research?
The keywords of their largest research topics: Parkinson's Disease, Mitochondrial Dysfunction, Neurological Disorders, Epilepsy, Neurodegeneration, Diagnostic Criteria, Deep Brain Stimulation and Subthalamic Nucleus.
- Paraneoplastic Syndromes
- Fragile X Syndrome
- Anti-NMDA Receptor Encephalitis
- Botulinum Toxin
- Glycogen
- Protein Aggregation
- a-Synuclein
- Subthalamic Nucleus
- Diagnostic Criteria
- Epilepsy
- Mitochondrial Dysfunction
- Parkinson's Disease
- Neurological Disorders
- Neurodegeneration
- Deep Brain Stimulation
- Dopaminergic Neurons
- Huntington's Disease
- Genetic Mutations
- Metabolism
- Neurotoxins
- Charcot-Marie-Tooth Disease
- Hereditary Spastic Paraplegia
- Rett Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Parkinson's Disease512 topics
- Mitochondrial Dysfunction473 topics
- Neurological Disorders373 topics
- Epilepsy352 topics
- Neurodegeneration322 topics
- Diagnostic Criteria282 topics
- Deep Brain Stimulation271 topic
- Subthalamic Nucleus271 topic
- Dopaminergic Neurons241 topic
- a-Synuclein241 topic
- Huntington's Disease191 topic
- Protein Aggregation191 topic
- Genetic Mutations163 topics
- Glycogen81 topic
- Metabolism81 topic
- Botulinum Toxin61 topic
- Neurotoxins61 topic
- Anti-NMDA Receptor Encephalitis41 topic
- Charcot-Marie-Tooth Disease41 topic
- Fragile X Syndrome41 topic
- Hereditary Spastic Paraplegia41 topic
- Paraneoplastic Syndromes41 topic
- Rett Syndrome41 topic
Where does Gerard Saranza work?
Gerard Saranza's main affiliation in the publication record is Chang Hua Hospital, Taiwan.
How many publications and citations does Gerard Saranza have?
OpenAlex counts 62 works and 595 citations for Gerard Saranza, an h-index of 13, ranking #3,004,513 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gerard Saranza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.